Section of Infectious Diseases, Boston University, Boston, Massachusetts, USA
Dr. Bhadelia is the founding director of BU Center for Emerging Infectious Diseases Policy and Research and an associate director of the National Emerging Infectious Diseases Laboratories (NEIDL), a state-of-the-art maximum containment research facility at BU. She is a board-certified infectious diseases physician and an internationally recognized leader in highly communicable and emerging infectious diseases (EIDs) with clinical, field, academic, and policy experience in pandemic preparedness and response.
Over the last decade, Dr. Bhadelia designed and served as the medical director of the Special Pathogens Unit (SPU), a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. Her work focuses on health systems and clinical response to emerging infections including medical countermeasure evaluation, diagnostic positioning, infection control policy development, and healthcare worker training. She also has experience with direct patient care, outbreak response, and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa. Dr. Bhadelia serves on state and national working groups focused on biodefense priority setting, development of clinical care guidelines, and medical countermeasures research. She has served as a subject matter expert to the US Centers for Disease Control and Prevention, Department of Defense (DoD), and World Bank.